Home › Funds › Atlas Venture Life Science Advisors, LLC › SION

Atlas Venture Life Science Advisors, LLC position in SION

SIONNA THERAPEUTICS INC · Health Care

Atlas Venture Life Science Advisors, LLC reported holding 2,995,602 shares of SION (SIONNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 2.50% of its reported portfolio and ranking #7 among its reported holdings. Atlas Venture Life Science Advisors, LLC has disclosed SION holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)3.00M sh
Reported value held$15.76M
Portfolio Weight2.50%
First reportedQ1 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Atlas Venture Life Science Advisors, LLC's SION position evolved

Atlas Venture Life Science Advisors, LLC first disclosed a stake in SION in Q1 2025 at 3,694,020 shares (US$38.6M). The position peaked in Q2 2026 at 2,995,602 shares, worth US$131.8M. Across 7 filings, Atlas Venture Life Science Advisors, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,995,602 shares valued at US$15.8M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.69M $38.64M New
Q2 2025 3.69M $64.09M Hold
Q3 2025 3.62M $106.33M Reduce
Q4 2025 3.00M $123.24M Reduce
Q1 2026 3.00M $120.09M Hold
Q2 2026 3.00M $131.78M Hold
Q3 2026 3.00M $15.76M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SION and 13F data

SION (SIONNA THERAPEUTICS INC) is a Health Care company. 60 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), ORBIMED ADVISORS LLC (US$112.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SION

All SION fund holders →

FAQ

How long has Atlas Venture Life Science Advisors, LLC held SION?

Atlas Venture Life Science Advisors, LLC has disclosed SION holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Atlas Venture Life Science Advisors, LLC's current position in SION?

As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 3.00M shares of SION (SIONNA THERAPEUTICS INC), valued at $15.76M, representing 2.50% of its reported portfolio and ranking #7.

Has Atlas Venture Life Science Advisors, LLC been buying or selling SION?

In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC held unchanged its position in SION. The position peaked in Q2 2026 at 3.00M shares.

Which other funds hold SION?

Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, ORBIMED ADVISORS LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.